Atsushi Matsumura
Chairman at NANO MRNA CO.,LTD.
Network origin in Atsushi Matsumura first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Advertising/Marketing Services | 14 | |
Whiz Partners, Inc.
Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010.
13
| Private Company | Investment Managers | 13 |
Public Company | Pharmaceuticals: Other | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Atsushi Matsumura via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HOSOKAWA MICRON CORPORATION | Industrial Machinery | Corporate Officer/Principal | |
FUJI ELECTRONICS CO., LTD. | Electronics Distributors | Comptroller/Controller/Auditor | |
BANK OF JAPAN | General Government | Corporate Officer/Principal | |
ANGES, INC. | Pharmaceuticals: Generic | Director of Finance/CFO | |
KLAB INC. | Packaged Software | Corporate Officer/Principal | |
University of Michigan | College/University | Graduate Degree | |
ADVANCED MEDIA, INC. | Packaged Software | Director/Board Member Director/Board Member | |
Mitsubishi UFJ Securities Holdings Co., Ltd.
Mitsubishi UFJ Securities Holdings Co., Ltd. Investment Banks/BrokersFinance Mitsubishi UFJ Securities Co. Ltd. provides securities services including dealing, brokering, underwriting, and distribution. It also provides management and investment, venture capital, real estate leasing, insurance agency, and data processing systems development. The company was founded on March 4, 1948 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Comptroller/Controller/Auditor | |
University of Tokyo | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Takeda Ventures, Inc.
Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
RENOWN INCORPORATED | Apparel/Footwear | Director/Board Member | |
Sidney Kimmel Medical College | College/University | Doctorate Degree | |
Veolia Japan KK
Veolia Japan KK Water UtilitiesUtilities Veolia Japan KK engages in the provision of water, energy and materials solutions focusing on waste receovery. Its services include operation and maintenance of water and wastewater treatment facilities; design, construction, and management of water and wastewater treatment facilities; pipe network management; platic recycling and renewable energy. The company was founded on May 1, 2002 and is headquartered in Tokyo, Japan. | Water Utilities | Corporate Officer/Principal | |
Nishihara Environment Technology, Inc.
Nishihara Environment Technology, Inc. Engineering & ConstructionIndustrial Services Part of Veolia Environnement SA, Nishihara Environment Technology, Inc. constructs and operates water treatment facilities. The company is based in Tokyo, Japan. | Engineering & Construction | Corporate Officer/Principal | |
Nihon Schering KK
Nihon Schering KK Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Nihon Schering KK is a Japanese company that manufactures pharmaceuticals and diagnostic substances. The company is based in Osaka, Japan. | Pharmaceuticals: Major | Director of Finance/CFO | |
KYOWA KIRIN CO. LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
D2C, Inc.
D2C, Inc. Advertising/Marketing ServicesCommercial Services D2C, Inc. engages in mobile marketing and advertising. It is involved in planning, digital marketing, media solutions, and content support along with business development and overseas services. The company was founded on June 1, 2000 and is headquartered in Tokyo, Japan. | Advertising/Marketing Services | Corporate Officer/Principal | |
ALBERT | Packaged Software | Director/Board Member Director/Board Member Director/Board Member | |
Tokyo Women's Medical University | College/University | Corporate Officer/Principal | |
CELLSEED INC. | Pharmaceuticals: Other | Director/Board Member | |
innovating.jp, Inc.
innovating.jp, Inc. Information Technology ServicesTechnology Services Innovating.jp, Inc. develops social application sites and provides mobile marketing support and mobile content development. The private company is based in Tokyo, Japan. | Information Technology Services | Director/Board Member | |
Mikatus Inc.
Mikatus Inc. Information Technology ServicesTechnology Services Mikatus Inc. provides accounting system solutions. It develops and sale of cloud-based accounting systems and tax application software for professional accounting firms. It also provides accounting equipment sales, systems maintenance, and portal site development. The company was founded by Toshinao Morizaki in June 2009 and is headquartered in Tokyo, Japan. | Information Technology Services | Chief Administrative Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin | |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Biotechnology | Director of Finance/CFO | |
D2C R, Inc.
D2C R, Inc. Advertising/Marketing ServicesCommercial Services Part of Nippon Telegraph & Telephone Corp., D2C R, Inc. is an apps advertising agency. The company is based in Tokyo, Japan. | Advertising/Marketing Services | Director/Board Member | |
Natori Law Office | Corporate Officer/Principal | ||
GORYO Chemical, Inc.
GORYO Chemical, Inc. Chemicals: Major DiversifiedProcess Industries GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan. | Chemicals: Major Diversified | Director of Finance/CFO | |
SHATTUCK LABS, INC. | Biotechnology | Director/Board Member | |
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Biotechnology | Chief Executive Officer | |
Tranzax Co., Ltd.
Tranzax Co., Ltd. Financial ConglomeratesFinance Tranzax Co., Ltd. is a Japanese company that combines the latest IT technology and financial knowledge to provide new funding opportunities for small and medium-sized enterprises and venture companies by utilizing commercial transactions as the root of business activities. The company is based in Tokyo, Japan. and has subsidiaries in Japan. The company was founded in 2009 by Takashi Ogura. | Financial Conglomerates | Director/Board Member | |
D2C X, Inc.
D2C X, Inc. Advertising/Marketing ServicesCommercial Services D2C X, Inc. engages in internet media management and marketing consultancy services. The company was founded in September 2013 and is headquartered in Tokyo, Japan. | Advertising/Marketing Services | Director/Board Member | |
Kakezan Inc. | Director/Board Member | ||
Gushcloud Japan Co., Ltd. | Director/Board Member | ||
D2C China Co., Ltd. | Director/Board Member | ||
Adaptate Biotherapeutics Ltd.
Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
ARTham Therapeutics, Inc.
ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Pharmaceuticals: Major | Director/Board Member | |
IgniteEye Corp.
IgniteEye Corp. Packaged SoftwareTechnology Services IgniteEye Corp. engages in the provision of cloud services for recruitment activities. Its cloud products include SONAR, Compass, Sniping and CREATIVE. The company was founded by Takashi Yoshida in May 2013 and is headquartered in Tokyo, Japan. | Packaged Software | Director/Board Member | |
Innovation Center of Nanomedicine | President | ||
Axcelead Drug Discovery Partners, Inc.
Axcelead Drug Discovery Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Axcelead Drug Discovery Partners, Inc. is a Japanese company founded in 2017 that provides services for the quality evaluation of new modality regenerative medical cells, effectiveness and safety evaluation of target cells, and bridging data. The company is based in Fujisawa, JP. and has subsidiaries in the United States. It is used by more than 100 facilities such as clients pharmaceutical companies, venture companies, and academia. Axcelead offers non-clinical development strategic planning and problem resolution services to its clients. | Miscellaneous Commercial Services | Director/Board Member | |
Iron City Micro Display, Inc. | Director/Board Member | ||
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
PIXTA INC. | Information Technology Services | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
Tokai Tokyo Securities Europe Ltd.
Tokai Tokyo Securities Europe Ltd. Investment Banks/BrokersFinance Part of Tokai Tokyo Financial Holdings, Inc., Tokai Tokyo Securities Europe Ltd. is a British company that provides security and flotation services. The company is based in London, UK. The company was founded in 2007. The CEO is Yoshihiko Kasahara. | Investment Banks/Brokers | Director/Board Member | |
Genomedia, Inc.
Genomedia, Inc. Miscellaneous Commercial ServicesCommercial Services Genomedia, Inc. is a Japanese company that provides one-stop and high-efficiency genome information analysis services, from sample preparation to software tool development. The company was founded in 2013 and is based in Tokyo, Japan. The company specializes in the development and provision of diagnostic services using genomic information, as well as the development of tools required to perform genome information analysis. | Miscellaneous Commercial Services | Chief Executive Officer | |
82VS | Investment Managers | President |
Statistics
International
Japan | 39 |
United States | 10 |
United Kingdom | 3 |
China | 2 |
Sectoral
Health Technology | 11 |
Technology Services | 9 |
Finance | 8 |
Consumer Services | 7 |
Commercial Services | 7 |
Operational
Director/Board Member | 89 |
President | 15 |
Corporate Officer/Principal | 14 |
Independent Dir/Board Member | 11 |
Private Equity Investor | 9 |
Most connected contacts
Insiders | |
---|---|
Ryutaro Katayama | 15 |
Takuma Nakatsuka | 13 |
Victor Stone | 12 |
Satoru Iino | 11 |
Takashi Ejiri | 8 |
Junji Oshita | 7 |
Hironobu Honma | 7 |
Kazunori Kataoka | 5 |
Tetsuhito Matsuyama | 5 |
Teruo Okano | 4 |
Yuki Hasegawa | 3 |
Hiroshi Takeda | 3 |
Tomoyuki Fujisawa | 3 |
Riichi Sato | 3 |
Shiro Akinaga | 3 |
- Stock Market
- Insiders
- Atsushi Matsumura
- Company connections